BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 37212317)

  • 1. Today's Kaposi sarcoma is not the same as it was 40 years ago, or is it?
    Damania B; Dittmer DP
    J Med Virol; 2023 May; 95(5):e28773. PubMed ID: 37212317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma--associated herpesvirus infection in patients with and without Kaposi sarcoma.
    Gill J; Bourboulia D; Wilkinson J; Hayes P; Cope A; Marcelin AG; Calvez V; Gotch F; Boshoff C; Gazzard B
    J Acquir Immune Defic Syndr; 2002 Dec; 31(4):384-90. PubMed ID: 12447008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical application of plasma Kaposi sarcoma herpesvirus viral load as a tumour biomarker: results from 704 patients.
    Haq IU; Dalla Pria A; Papanastasopoulos P; Stegmann K; Bradshaw D; Nelson M; Bower M
    HIV Med; 2016 Jan; 17(1):56-61. PubMed ID: 26111246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions.
    El-Mallawany NK; Mehta PS; Kamiyango W; Villiera J; Peckham-Gregory EC; Kampani C; Krysiak R; Sanders MK; Caro-Vegas C; Eason AB; Ahmed S; Schutze GE; Martin SC; Kazembe PN; Scheurer ME; Dittmer DP
    Int J Cancer; 2019 Jan; 144(1):110-116. PubMed ID: 30204240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily.
    Amodio E; Goedert JJ; Barozzi P; Riva G; Firenze A; Bonura F; Viviano E; Romano N; Luppi M
    Cancer Sci; 2011 Oct; 102(10):1769-73. PubMed ID: 21740480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi sarcoma-associated herpesvirus, HIV-1 and Kaposi sarcoma risk in black South Africans diagnosed with cancer during antiretroviral treatment rollout.
    Motlhale M; Muchengeti M; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Bender N; Mathew CG; Newton R; Waterboer T; Singh E; Sitas F
    Int J Cancer; 2023 May; 152(10):2081-2089. PubMed ID: 36727526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
    Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
    J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar Immunological Profiles Between African Endemic and Human Immunodeficiency Virus Type 1-Associated Epidemic Kaposi Sarcoma (KS) Patients Reveal the Primary Role of KS-Associated Herpesvirus in KS Pathogenesis.
    Lidenge SJ; Tso FY; Ngalamika O; Ngowi JR; Mortazavi Y; Kwon EH; Shea DM; Minhas V; Mwaiselage J; Wood C; West JT
    J Infect Dis; 2019 Apr; 219(8):1318-1328. PubMed ID: 30452681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of quantitative Kaposi sarcoma--associated herpesvirus load in posttransplantation Kaposi sarcoma.
    Pellet C; Chevret S; Francès C; Euvrard S; Hurault M; Legendre C; Dalac S; Farge D; Antoine C; Hiesse C; Peraldi MN; Lang P; Samuel D; Calmus Y; Agbalika F; Morel P; Calvo F; Lebbé C
    J Infect Dis; 2002 Jul; 186(1):110-3. PubMed ID: 12089670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
    Engels EA; Biggar RJ; Marshall VA; Walters MA; Gamache CJ; Whitby D; Goedert JJ
    AIDS; 2003 Aug; 17(12):1847-51. PubMed ID: 12891072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.
    Uldrick TS; Wang V; O'Mahony D; Aleman K; Wyvill KM; Marshall V; Steinberg SM; Pittaluga S; Maric I; Whitby D; Tosato G; Little RF; Yarchoan R
    Clin Infect Dis; 2010 Aug; 51(3):350-8. PubMed ID: 20583924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
    Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene.
    Tso FY; West JT; Wood C
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-infection and co-localization of Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus in HIV-associated Kaposi sarcoma: a case report.
    Julius P; Kang G; Siyumbwa S; Musumali J; Tso FY; Ngalamika O; Kaile T; Maate F; Moonga P; West JT; Angeletti P; Wood C
    Front Cell Infect Microbiol; 2023; 13():1270935. PubMed ID: 37928187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease.
    Marcelin AG; Motol J; Guihot A; Caumes E; Viard JP; Dussaix E; Cadranel J; Frances C; Carcelain G; Calvez V; Dupin N
    J Infect Dis; 2007 Oct; 196(8):1163-6. PubMed ID: 17955434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.
    Wen KW; Damania B
    Cancer Lett; 2010 Mar; 289(2):140-50. PubMed ID: 19651473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
    Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
    AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of Kaposi's sarcoma-associated herpesvirus in blood, oral mucosa, and saliva in patients with Kaposi's sarcoma.
    Marcelin AG; Gorin I; Morand P; Ait-Arkoub Z; Deleuze J; Morini JP; Calvez V; Dupin N
    AIDS Res Hum Retroviruses; 2004 Jul; 20(7):704-8. PubMed ID: 15307914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study.
    Letang E; Almeida JM; Miró JM; Ayala E; White IE; Carrilho C; Bastos R; Nhampossa T; Menéndez C; Campbell TB; Alonso PL; Naniche D
    J Acquir Immune Defic Syndr; 2010 Apr; 53(5):589-97. PubMed ID: 19801945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS).
    Polizzotto MN; Uldrick TS; Wyvill KM; Aleman K; Marshall V; Wang V; Whitby D; Pittaluga S; Jaffe ES; Millo C; Tosato G; Little RF; Steinberg SM; Sereti I; Yarchoan R
    Clin Infect Dis; 2016 Mar; 62(6):730-738. PubMed ID: 26658701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.